0001602462-15-000001.txt : 20150309 0001602462-15-000001.hdr.sgml : 20150309 20150306195428 ACCESSION NUMBER: 0001602462-15-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150306 EFFECTIVENESS DATE: 20150309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KinDex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001602462 IRS NUMBER: 270767031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-213543 FILM NUMBER: 15683178 BUSINESS ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 447-1455 MAIL ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D/A 1 primary_doc.xml X0707 D/A LIVE 0001602462 KinDex Pharmaceuticals, Inc. 800 FIFTH AVENUE STE. 4100 SEATTLE WA WASHINGTON 98104 (206) 922-2912 DELAWARE KinDex Therapeutics, LLC None Corporation true Jeffrey S Bland 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Roger Colman 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Jeffrey J Katke 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Paul Schimmel 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Neile A Grayson 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Lincoln Bouillon 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001602462-14-000001 2014-03-04 true true false 0 10000000 5500000 4500000 false 6 0 0 0 false KinDex Pharmaceuticals, Inc. Lincoln Bouillon Lincoln Bouillon Chief Financial Officer 2015-03-06